STEVANATO GROUP SPA (STVN) Fundamental Analysis & Valuation

NYSE:STVN • IT0005452658

Current stock price

13.47 USD
+0.04 (+0.3%)
Last:

This STVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. STVN Profitability Analysis

1.1 Basic Checks

  • STVN had positive earnings in the past year.
  • In the past year STVN had a positive cash flow from operations.
  • STVN had positive earnings in each of the past 5 years.
  • Each year in the past 5 years STVN had a positive operating cash flow.
STVN Yearly Net Income VS EBIT VS OCF VS FCFSTVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • The Return On Assets of STVN (5.50%) is better than 82.14% of its industry peers.
  • STVN has a Return On Equity of 9.41%. This is amongst the best in the industry. STVN outperforms 80.36% of its industry peers.
  • With an excellent Return On Invested Capital value of 7.60%, STVN belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for STVN is below the industry average of 11.80%.
Industry RankSector Rank
ROA 5.5%
ROE 9.41%
ROIC 7.6%
ROA(3y)5.86%
ROA(5y)7.13%
ROE(3y)10.22%
ROE(5y)12.19%
ROIC(3y)8.19%
ROIC(5y)9.45%
STVN Yearly ROA, ROE, ROICSTVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • STVN has a better Profit Margin (11.79%) than 80.36% of its industry peers.
  • In the last couple of years the Profit Margin of STVN has remained more or less at the same level.
  • STVN's Operating Margin of 17.70% is amongst the best of the industry. STVN outperforms 80.36% of its industry peers.
  • In the last couple of years the Operating Margin of STVN has grown nicely.
  • Looking at the Gross Margin, with a value of 29.60%, STVN is doing worse than 75.00% of the companies in the same industry.
  • STVN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.7%
PM (TTM) 11.79%
GM 29.6%
OM growth 3Y-2.89%
OM growth 5Y2.66%
PM growth 3Y-6.71%
PM growth 5Y-0.12%
GM growth 3Y-3.41%
GM growth 5Y0.18%
STVN Yearly Profit, Operating, Gross MarginsSTVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 10 20 30

4

2. STVN Health Analysis

2.1 Basic Checks

  • STVN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, STVN has about the same amount of shares outstanding.
  • The number of shares outstanding for STVN has been reduced compared to 5 years ago.
  • The debt/assets ratio for STVN has remained at the same level compared to a year ago.
STVN Yearly Shares OutstandingSTVN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
STVN Yearly Total Debt VS Total AssetsSTVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • STVN has an Altman-Z score of 3.74. This indicates that STVN is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of STVN (3.74) is better than 76.79% of its industry peers.
  • STVN has a debt to FCF ratio of 42.45. This is a negative value and a sign of low solvency as STVN would need 42.45 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 42.45, STVN is in line with its industry, outperforming 55.36% of the companies in the same industry.
  • A Debt/Equity ratio of 0.25 indicates that STVN is not too dependend on debt financing.
  • STVN has a Debt to Equity ratio (0.25) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 42.45
Altman-Z 3.74
ROIC/WACC0.9
WACC8.47%
STVN Yearly LT Debt VS Equity VS FCFSTVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • STVN has a Current Ratio of 1.76. This is a normal value and indicates that STVN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of STVN (1.76) is worse than 71.43% of its industry peers.
  • STVN has a Quick Ratio of 1.26. This is a normal value and indicates that STVN is financially healthy and should not expect problems in meeting its short term obligations.
  • STVN has a Quick ratio of 1.26. This is in the lower half of the industry: STVN underperforms 73.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.26
STVN Yearly Current Assets VS Current LiabilitesSTVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

7

3. STVN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.42% over the past year.
  • The Earnings Per Share has been growing by 13.67% on average over the past years. This is quite good.
  • STVN shows a small growth in Revenue. In the last year, the Revenue has grown by 7.45%.
  • The Revenue has been growing by 12.37% on average over the past years. This is quite good.
EPS 1Y (TTM)10.42%
EPS 3Y-1.23%
EPS 5Y13.67%
EPS Q2Q%-5.26%
Revenue 1Y (TTM)7.45%
Revenue growth 3Y6.44%
Revenue growth 5Y12.37%
Sales Q2Q%4.81%

3.2 Future

  • Based on estimates for the next years, STVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.96% on average per year.
  • The Revenue is expected to grow by 16.47% on average over the next years. This is quite good.
EPS Next Y21.82%
EPS Next 2Y23.67%
EPS Next 3Y22.7%
EPS Next 5Y19.96%
Revenue Next Year8.69%
Revenue Next 2Y9.34%
Revenue Next 3Y9.39%
Revenue Next 5Y16.47%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
STVN Yearly Revenue VS EstimatesSTVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
STVN Yearly EPS VS EstimatesSTVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

5

4. STVN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 22.08 indicates a rather expensive valuation of STVN.
  • Based on the Price/Earnings ratio, STVN is valued a bit cheaper than the industry average as 78.57% of the companies are valued more expensively.
  • STVN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.89.
  • STVN is valuated rather expensively with a Price/Forward Earnings ratio of 18.11.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of STVN indicates a rather cheap valuation: STVN is cheaper than 80.36% of the companies listed in the same industry.
  • STVN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.08
Fwd PE 18.11
STVN Price Earnings VS Forward Price EarningsSTVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, STVN is valued cheaper than 85.71% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of STVN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 320.68
EV/EBITDA 12.86
STVN Per share dataSTVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

  • STVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • STVN has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as STVN's earnings are expected to grow with 22.70% in the coming years.
PEG (NY)1.01
PEG (5Y)1.62
EPS Next 2Y23.67%
EPS Next 3Y22.7%

3

5. STVN Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.45%, STVN is not a good candidate for dividend investing.
  • In the last 3 months the price of STVN has falen by -35.12%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • STVN's Dividend Yield is rather good when compared to the industry average which is at 0.11. STVN pays more dividend than 87.50% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, STVN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.45%

5.2 History

  • STVN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
STVN Yearly Dividends per shareSTVN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.02 0.04 0.06 0.08

5.3 Sustainability

  • STVN pays out 10.54% of its income as dividend. This is a sustainable payout ratio.
DP10.54%
EPS Next 2Y23.67%
EPS Next 3Y22.7%
STVN Yearly Income VS Free CF VS DividendSTVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M
STVN Dividend Payout.STVN Dividend Payout, showing the Payout Ratio.STVN Dividend Payout.PayoutRetained Earnings

STVN Fundamentals: All Metrics, Ratios and Statistics

STEVANATO GROUP SPA

NYSE:STVN (3/30/2026, 4:15:00 PM)

13.47

+0.04 (+0.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-04
Earnings (Next)05-01
Inst Owners108.49%
Inst Owner Change-7.48%
Ins Owners1.61%
Ins Owner Change0%
Market Cap4.08B
Revenue(TTM)1.19B
Net Income(TTM)139.84M
Analysts83.53
Price Target26.41 (96.07%)
Short Float %3.17%
Short Ratio2.18
Dividend
Industry RankSector Rank
Dividend Yield 0.45%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP10.54%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.52%
Min EPS beat(2)4.36%
Max EPS beat(2)10.69%
EPS beat(4)4
Avg EPS beat(4)7.01%
Min EPS beat(4)2.71%
Max EPS beat(4)10.69%
EPS beat(8)5
Avg EPS beat(8)-2.34%
EPS beat(12)6
Avg EPS beat(12)-2.92%
EPS beat(16)10
Avg EPS beat(16)-0.77%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.01%
Max Revenue beat(2)2.36%
Revenue beat(4)4
Avg Revenue beat(4)2.11%
Min Revenue beat(4)1.72%
Max Revenue beat(4)2.36%
Revenue beat(8)5
Avg Revenue beat(8)0.72%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)7
Avg Revenue beat(16)-0.11%
PT rev (1m)-2.76%
PT rev (3m)-2.76%
EPS NQ rev (1m)-6.32%
EPS NQ rev (3m)-6.73%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)-0.1%
Revenue NQ rev (1m)-2.28%
Revenue NQ rev (3m)-2.39%
Revenue NY rev (1m)-0.84%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 22.08
Fwd PE 18.11
P/S 2.99
P/FCF 320.68
P/OCF 12.38
P/B 2.38
P/tB 2.53
EV/EBITDA 12.86
EPS(TTM)0.61
EY4.53%
EPS(NY)0.74
Fwd EY5.52%
FCF(TTM)0.04
FCFY0.31%
OCF(TTM)1.09
OCFY8.08%
SpS4.51
BVpS5.65
TBVpS5.32
PEG (NY)1.01
PEG (5Y)1.62
Graham Number8.81
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 9.41%
ROCE 10.46%
ROIC 7.6%
ROICexc 8.12%
ROICexgc 8.5%
OM 17.7%
PM (TTM) 11.79%
GM 29.6%
FCFM 0.93%
ROA(3y)5.86%
ROA(5y)7.13%
ROE(3y)10.22%
ROE(5y)12.19%
ROIC(3y)8.19%
ROIC(5y)9.45%
ROICexc(3y)8.65%
ROICexc(5y)11.89%
ROICexgc(3y)9.1%
ROICexgc(5y)12.95%
ROCE(3y)11.5%
ROCE(5y)13.09%
ROICexgc growth 3Y-19.23%
ROICexgc growth 5Y-14.21%
ROICexc growth 3Y-18.12%
ROICexc growth 5Y-11.91%
OM growth 3Y-2.89%
OM growth 5Y2.66%
PM growth 3Y-6.71%
PM growth 5Y-0.12%
GM growth 3Y-3.41%
GM growth 5Y0.18%
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 42.45
Debt/EBITDA 1.26
Cap/Depr 310.54%
Cap/Sales 23.18%
Interest Coverage 30.18
Cash Conversion 95.81%
Profit Quality 7.9%
Current Ratio 1.76
Quick Ratio 1.26
Altman-Z 3.74
F-Score5
WACC8.47%
ROIC/WACC0.9
Cap/Depr(3y)420.82%
Cap/Depr(5y)367.66%
Cap/Sales(3y)30.77%
Cap/Sales(5y)26.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.42%
EPS 3Y-1.23%
EPS 5Y13.67%
EPS Q2Q%-5.26%
EPS Next Y21.82%
EPS Next 2Y23.67%
EPS Next 3Y22.7%
EPS Next 5Y19.96%
Revenue 1Y (TTM)7.45%
Revenue growth 3Y6.44%
Revenue growth 5Y12.37%
Sales Q2Q%4.81%
Revenue Next Year8.69%
Revenue Next 2Y9.34%
Revenue Next 3Y9.39%
Revenue Next 5Y16.47%
EBIT growth 1Y16.22%
EBIT growth 3Y3.37%
EBIT growth 5Y15.36%
EBIT Next Year70.19%
EBIT Next 3Y33.51%
EBIT Next 5Y26.17%
FCF growth 1Y107%
FCF growth 3YN/A
FCF growth 5Y-28.64%
OCF growth 1Y83.65%
OCF growth 3Y40.43%
OCF growth 5Y12.94%

STEVANATO GROUP SPA / STVN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of STEVANATO GROUP SPA (STVN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to STVN.


What is the valuation status of STEVANATO GROUP SPA (STVN) stock?

ChartMill assigns a valuation rating of 5 / 10 to STEVANATO GROUP SPA (STVN). This can be considered as Fairly Valued.


How profitable is STEVANATO GROUP SPA (STVN) stock?

STEVANATO GROUP SPA (STVN) has a profitability rating of 7 / 10.


Can you provide the financial health for STVN stock?

The financial health rating of STEVANATO GROUP SPA (STVN) is 4 / 10.


Can you provide the dividend sustainability for STVN stock?

The dividend rating of STEVANATO GROUP SPA (STVN) is 3 / 10 and the dividend payout ratio is 10.54%.